Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
View on Grants.gov ↗ Sign in to save
- Type
- Grant
- Notice type
- G
- Agency
- National Institutes of Health
- Sub-agency
- HHS-NIH11
- Solicitation #
- RFA-DA-26-034
- Posted
- Nov 20, 2024
- Response due
- Nov 18, 2027
- Archive date
- Dec 24, 2027
- CFDA / Assistance listing
- 93.233,93.279,93.837,93.838,93.839,93.840,93.855
- Award ceiling
- $300,000
- Total program funding
- $300,000
- Contact
- grantsinfo@nih.gov
- Source
- Grants.gov
Description
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.